piperaquine has been researched along with Disease Models, Animal in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 9 (60.00) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Andrzejewski, C; Batty, KT; Ilett, KF; Jago, JD; Moore, BR; Page-Sharp, M | 1 |
| Bane, CE; Black, C; Butler, K; Caridha, D; Cooper, RA; Dodean, RA; Gaona, H; Gaynor-Ohnstad, L; Huezo, SJ; Kancharla, P; Kelly, JX; Kreishman-Deitrick, M; Leed, SE; Li, Q; Li, Y; Lin, H; Luong, TL; Marcsisin, S; Melendez, V; Nolan, C; Olmeda, R; Potter, B; Pou, S; Rasmussen, SA; Read, L; Riscoe, MK; Roncal, N; Sciotti, RJ; Smilkstein, MJ; Sousa, J; Stephens, MT; Tan, JC; Vesely, B; Vuong, C; Winter, RW; Xie, L; Zeng, Q; Zhang, J; Zhang, P | 1 |
| Bane, CE; Bayles, BR; Black, C; Butler, K; Caridha, D; Ceja, FG; Cooper, RA; Dodean, RA; Gaona, H; Gaynor-Ohnstad, L; Kancharla, P; Kelly, JX; Kreishman-Deitrick, M; Leed, SE; Li, Q; Li, Y; Lin, H; Luong, TL; Marcsisin, S; Melendez, V; Mu, J; Nolan, C; Olmeda, R; Potter, B; Pou, S; Pybus, B; Rasmussen, SA; Read, L; Reynolds, KA; Riscoe, MK; Roncal, N; Rosenthal, PJ; Sciotti, RJ; Smilkstein, MJ; Sousa, J; Tumwebaze, PK; Vesely, B; Vuong, C; Xie, L; Zeng, Q; Zhang, J; Zhang, P | 1 |
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Guo, H; Huang, X; Lu, F; Ye, Z; Yi, G; Zhou, L | 1 |
| Batty, KT; Gibbons, PL; Kirkpatrick, CM; Moore, BR; Patel, K | 1 |
| Borrmann, S; Heiss, K; Meister, M; Mueller, AK; Pfeil, J; Sepp, KJ | 1 |
| Amer, EI; El-Faham, MH; Mossallam, SF | 1 |
| Burugu, MW; Gimode, WR; Kiboi, DM; Kimani, FT; Muregi, FW; Wamakima, HN | 1 |
| Sullivan, DJ; Walker, LA | 1 |
| Abiodun, O; Bell, A; Brun, R; Chollet, J; Irungu, BN; Kiboi, DM; Langat, B; Nganga, JK; Nyambati, VC; Nzila, A; Rukunga, GM; Wittlin, S | 1 |
| Batty, KT; Ilett, KF; Jago, JD; Moore, BR; Page-Sharp, M | 1 |
| Bentura-Marciano, A; Chan, WC; Clark, J; Golenser, J; Guiguemde, AW; Guo, J; Guy, RK; Haynes, RK; Hunt, NH; Wong, HN | 1 |
| Guo, H; Huang, XX; Pan, ZY; Wu, JY; Xue, WL; Yi, GH; Zhou, LM | 1 |
| Chollet, J; Santo-Tomas, J; Scheurer, C; Snyder, C; Wittlin, S | 1 |
15 other study(ies) available for piperaquine and Disease Models, Animal
| Article | Year |
|---|---|
Pharmacokinetics and pharmacodynamics of piperaquine in a murine malaria model.
Topics: Animals; Antimalarials; Artemisinins; Disease Models, Animal; Drug Therapy, Combination; Humans; Malaria; Male; Mice; Parasitemia; Plasmodium berghei; Quinolines; Sesquiterpenes; Treatment Outcome | 2008 |
Discovery and Structural Optimization of Acridones as Broad-Spectrum Antimalarials.
Topics: Acridones; Animals; Antimalarials; Disease Models, Animal; Drug Discovery; Hep G2 Cells; Humans; Malaria; Mice; Plasmodium; Species Specificity; Structure-Activity Relationship | 2019 |
Lead Optimization of Second-Generation Acridones as Broad-Spectrum Antimalarials.
Topics: Acridones; Administration, Oral; Animals; Antimalarials; Cell Survival; Disease Models, Animal; Female; Half-Life; Hep G2 Cells; Humans; Life Cycle Stages; Malaria; Male; Mice; Mice, Inbred C57BL; Plasmodium falciparum; Structure-Activity Relationship | 2020 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Infectivity and Screening of Anti-piperaquine Genes in Mice Infected with Piperaquine-Sensitive and Piperaquine-Resistant Plasmodium berghei.
Topics: Animals; Antimalarials; Disease Models, Animal; Humans; Malaria; Male; Mice; Plasmodium berghei; Protozoan Proteins; Quinolines; Virulence | 2019 |
Predicting the parasite killing effect of artemisinin combination therapy in a murine malaria model.
Topics: Animals; Antimalarials; Artemisinins; Disease Models, Animal; Drug Combinations; Malaria; Mice; Parasite Load; Parasitic Sensitivity Tests; Plasmodium berghei; Quinolines; Recurrence | 2014 |
Protection against malaria by immunization with non-attenuated sporozoites under single-dose piperaquine-tetraphosphate chemoprophylaxis.
Topics: Animals; CD8-Positive T-Lymphocytes; Chemoprevention; Chloroquine; Disease Models, Animal; Female; Immunologic Memory; Liver; Malaria; Malaria Vaccines; Mice, Inbred C57BL; Plasmodium berghei; Quinolines; Spleen; Sporozoites | 2014 |
Efficacy of Synriam™, a new antimalarial combination of OZ277 and piperaquine, against different developmental stages of Schistosoma mansoni.
Topics: Adolescent; Animals; Antimalarials; Cricetinae; Disease Models, Animal; Drug Combinations; Heterocyclic Compounds, 1-Ring; Humans; India; Mice; Microscopy, Electron; Peroxides; Praziquantel; Quinolines; Schistosoma mansoni; Schistosomiasis mansoni; Spiro Compounds | 2015 |
Fitness cost of resistance for lumefantrine and piperaquine-resistant Plasmodium berghei in a mouse model.
Topics: Animals; Antimalarials; Disease Models, Animal; Drug Resistance; Ethanolamines; Fluorenes; Genetic Fitness; Lumefantrine; Malaria; Male; Mice; Plasmodium berghei; Quinolines | 2015 |
Impact of Extended Duration of Artesunate Treatment on Parasitological Outcome in a Cytocidal Murine Malaria Model.
Topics: Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Disease Models, Animal; Female; Malaria; Mice; Mice, Inbred BALB C; Quinolines | 2017 |
Plasmodium berghei ANKA: selection of resistance to piperaquine and lumefantrine in a mouse model.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Chloroquine; Disease Models, Animal; Drug Resistance; Ethanolamines; Female; Fluorenes; Lumefantrine; Malaria; Male; Mice; Parasitemia; Plasmodium berghei; Quinolines; Serial Passage | 2009 |
Piperaquine pharmacodynamics and parasite viability in a murine malaria model.
Topics: Animals; Antimalarials; Disease Models, Animal; Malaria; Male; Mice; Mice, Inbred BALB C; Plasmodium berghei; Quinolines | 2009 |
Synthesis of artemiside and its effects in combination with conventional drugs against severe murine malaria.
Topics: Animals; Antimalarials; Artemisinins; Disease Models, Animal; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; High-Throughput Screening Assays; Humans; Inhibitory Concentration 50; Malaria, Cerebral; Malaria, Falciparum; Mefloquine; Mice; Mice, Inbred C57BL; Microscopy; Parasitemia; Plasmodium berghei; Plasmodium falciparum; Quinolines; Secondary Prevention; Survival Rate | 2012 |
[Immunological analysis of piperaquine-resistant murine model of Plasmodium berghei ANKA strain].
Topics: Animals; Cells, Cultured; Disease Models, Animal; Drug Resistance; Interferon-gamma; Lymphocytes; Malaria; Male; Mice; Mice, Inbred Strains; Nitric Oxide; Plasmodium berghei; Quinolines; Spleen | 2012 |
In vitro and in vivo interaction of synthetic peroxide RBx11160 (OZ277) with piperaquine in Plasmodium models.
Topics: Animals; Antimalarials; Artemether; Artemisinins; Atovaquone; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Erythrocytes; Female; Heterocyclic Compounds, 1-Ring; Humans; Malaria; Mice; Parasitemia; Parasitic Sensitivity Tests; Peroxides; Plasmodium berghei; Plasmodium falciparum; Pyrimethamine; Quinolines; Spiro Compounds | 2007 |